SpringWorks Therapeutics (NASDAQ:SWTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SpringWorks Therapeutics Stock (NASDAQ: SWTX) stock price, news, charts, stock research, profile.

Open	$33.57
Close	$35.59
Volume / Avg.	1.40M / 1.28M
Day Range	$33.57 - $36.09
52 Wk Range	28.21 - 53.92
Market Cap	$2.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	19.96%
Days to Cover	12.2

Recent News

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?

Lekha Gupta

SpringWorks Q2 Earnings Beat, Ogsiveo Drives Revenues

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) incurred a loss of 54 cents per share in the second quarter of 2024, which was significantly narrower than the Zacks Consensus Estimate of a loss of $1.12. The company had reported a loss of $1.25 per share in the year-ago quarter.

Zacks

Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving

SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a publ

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$33.57
Close	$35.59
Volume / Avg.	1.40M / 1.28M
Day Range	$33.57 - $36.09
52 Wk Range	28.21 - 53.92
Market Cap	$2.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	19.96%
Days to Cover	12.2

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SpringWorks Therapeutics (SWTX) stock?

You can purchase shares of SpringWorks Therapeutics (NASDAQ:SWTX) through any online brokerage.

View our list of the best stock brokerages

Who are SpringWorks Therapeutics (SWTX) competitors?

Other companies in SpringWorks Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for SpringWorks Therapeutics (SWTX) stock?

SpringWorks Therapeutics has a consensus price target of $63.75.

What is the current price for SpringWorks Therapeutics (SWTX)?

The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $35.59 last updated January 16, 2025 at 4:00 PM EST.

Does SpringWorks Therapeutics (SWTX) pay a dividend?

There are no upcoming dividends for SpringWorks Therapeutics.

When is SpringWorks Therapeutics (NASDAQ:SWTX) reporting earnings?

SpringWorks Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Is SpringWorks Therapeutics (SWTX) going to split?

There is no upcoming split for SpringWorks Therapeutics.

What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

SpringWorks Therapeutics

SpringWorks Therapeutics (SWTX) Forecast